These effects, together with a former report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two help the strategy of focusing on ACKR3 as a unique strategy to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Problems. By ticking this box https://annp405ctk0.ssnblog.com/profile